|
1
|
Tang Y, Xu F, Tao K, Qian N and Toi M:
Clinical applications of sentinel lymph node biopsy in ductal
carcinoma in situ of the breast: A dilemma. Tohoku J Exp Med.
224:1–5. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Calhoun BC and Collins LC: Predictive
markers in breast cancer: An update on ER and HER2 testing and
reporting. Semin Diagn Pathol. 32:362–369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Howat JM, Barnes DM, Harris M and Swindell
R: The association of cytosol oestrogen and progesterone receptors
with histological features of breast cancer and early recurrence of
disease. Br J Cancer. 47:629–640. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fisher ER, Costantino J, Fisher B and
Redmond C: Pathologic findings from the National Surgical Adjuvant
Breast Project (Protocol 4). Discriminants for 15-year survival.
National Surgical Adjuvant Breast and Bowel Project Investigators.
Cancer. 71:(Suppl 6). 2141–2150. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pantel K and Brakenhoff RH: Dissecting the
metastatic cascade. Nat Rev Cancer. 4:448–456. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ponzone R, Maggiorotto F, Mariani L,
Jacomuzzi ME, Magistris A, Mininanni P, Biglia N and Sismondi P:
Comparison of two models for the prediction of nonsentinel node
metastases in breast cancer. Am J Surg. 193:686–692. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gurleyik G, Aker F, Aktekin A and Saglam
A: Tumor characteristics influencing non-sentinel lymph node
involvement in clinically node negative patients with breast
cancer. J Breast Cancer. 14:124–128. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wallwiener CW, Wallwiener M, Kurth RR,
Röhm C, Neubauer H, Banys MJ, Staebler A, Schönfisch B, Meuer SC,
Giese T and Fehm TN: Molecular detection of breast cancer
metastasis in sentinel lymph nodes by reverse transcriptase
polymerase chain reaction (RT-PCR): Identifying, evaluating and
establishing multi-marker panels. Breast Cancer Res Treat.
130:833–844. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cavalli LR: Molecular markers of breast
axillary lymph node metastasis. Expert Rev Mol Diagn. 9:441–454.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yenidunya S, Bayrak R and Haltas H:
Predictive value of pathological and immunohistochemical parameters
for axillary lymph node metastasis in breast carcinoma. Diagn
Pathol. 6:182011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cserni G, Burzykowski T, Vinh-Hung V,
Kocsis L, Boross G, Sinkó M, Tarján M, Bori R, Rajtár M, Tekle E,
et al: Axillary sentinel node and tumour-related factors associated
with non-sentinel node involvement in breast cancer. Jpn J Clin
Oncol. 34:519–524. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hung WK, Chan MC, Mak KL, Chong SF, Lau Y,
Ho CM and Yip AW: Non-sentinel lymph node metastases in breast
cancer patients with metastatic sentinel nodes. ANZ J Surg.
75:27–31. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marrazzo A, Boscaino G, Marrazzo E,
Taormina P and Toesca A: Breast cancer subtypes can be determinant
in the decision making process to avoid surgical axillary staging:
A retrospective cohort study. Int J Surg. 21:156–161. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Veronesi U, Galimberti V, Zurrida S,
Pigatto F, Veronesi P, Robertson C, Paganelli G, Sciascia V and
Viale G: Sentinel lymph node biopsy as an indicator for axillary
dissection in early breast cancer. Eur J Cancer. 37:454–458. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Newman EA and Newman LA: Lymphatic mapping
techniques and sentinel lymph node biopsy in breast cancer. Surg
Clin North Am. 87353–364. (viii)2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Blumencranz PW, Pieretti M, Allen KG and
Blumencranz LE: Molecular analysis of breast sentinel lymph nodes.
Surg Oncol Clin N Am. 20467–485. (viii)2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Backus J, Laughlin T, Wang Y, Belly R,
White R, Baden J, Min C Justus, Mannie A, Tafra L, Atkins D and
Verbanac KM: Identification and characterization of optimal gene
expression markers for detection of breast cancer metastasis. J Mol
Diagn. 7:327–336. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Abdul-Rasool S, Kidson SH, Panieri E, Dent
D, Pillay K and Hanekom GS: An evaluation of molecular markers for
improved detection of breast cancer metastases in sentinel nodes. J
Clin Pathol. 59:289–297. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patani NR, Dwek MV and Douek M: Predictors
of axillary lymph node metastasis in breast cancer: A systematic
review. Eur J Surg Oncol. 33:409–419. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kurosumi M and Takei H: Significance and
problems of histopathological examination and utility of real-time
reverse transcriptase-polymerase chain reaction method for the
detection of sentinel lymph node metastasis in breast cancer.
Breast Cancer. 14:342–349. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Canevari RA, Marchi FA, Domingues MA, de
Andrade VP, Caldeira JR, Verjovski-Almeida S, Rogatto SR and Reis
EM: Identification of novel biomarkers associated with poor patient
outcomes in invasive breast carcinoma. Tumor Biol. Aug 2–2016.(Epub
ahead of print). View Article : Google Scholar
|
|
22
|
World Health Organization, . International
Classification of Diseases for Oncology. Third. World Health
Organization; Geneva: 2000
|
|
23
|
UICCTMN, . Classificação dos Tumores
MalignosMinistério da Saúde. 7th. Rio de; Janeiro: 2007
|
|
24
|
Bloom HJ and Richardson WW: Histological
grading and prognosis in breast cancer; a study of 1409 cases of
which 359 have been followed for 15 years. Br J Cancer. 11:359–377.
1957. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McNeill RE, Miller N and Kerin MJ:
Evaluation and validation of candidate endogenous control genes for
real-time quantitative PCR studies of breast cancer. BMC Mol Biol.
8:1072007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ellsworth RE, Field LA, Love B, Kane JL,
Hooke JA and Shriver CD: Differential gene expression in primary
breast tumors associated with lymph node metastasis. Int J Breast
Cancer. 2011:1427632011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nguyen DX and Massagué J: Genetic
determinants of cancer metastasis. Nat Rev Genet. 8:341–352. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Michaelson JS, Silverstein M, Sgroi D,
Cheongsiatmoy JA, Taghian A, Powell S, Hughes K, Comegno A, Tanabe
KK and Smith B: The effect of tumor size and lymph node status on
breast carcinoma lethality. Cancer. 98:2133–2143. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mansel RE, Goyal A and Newcombe RG:
ALMANAC Trialists Group: Internal mammary node drainage and its
role in sentinel lymph node biopsy: The initial ALMANAC experience.
Clin Breast Cancer. 5:279–286. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bertucci F, Houlgatte R, Benziane A,
Granjeaud S, Adélaïde J, Tagett R, Loriod B, Jacquemier J, Viens P,
Jordan B, et al: Gene expression profiling of primary breast
carcinomas using arrays of candidate genes. Hum Mol Genet.
9:2981–2991. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang E, Cheng SH, Dressman H, Pittman J,
Tsou MH, Horng CF, Bild A, Iversen ES, Liao M, Chen CM, et al: Gene
expression predictors of breast cancer outcomes. Lancet.
361:1590–1596. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abba MC, Sun H, Hawkins KA, Drake JA, Hu
Y, Nunez MI, Gaddis S, Shi T, Horvath S, Sahin A, et al: Breast
cancer molecular signatures as determined by SAGE: Correlation with
lymph node status. Mol Cancer Res. 5:881–890. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
van't Veer LJ, Dai H, van de Vijver MJ, He
YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ,
Witteveen AT, et al: Gene expression profiling predicts clinical
outcome of breast cancer. Nature. 415:530–536. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Weigelt B, Hu Z, He X, Livasy C, Carey LA,
Ewend MG, Glas AM, Perou CM and Van't Veer LJ: Molecular portraits
and 70-gene prognosis signature are preserved throughout the
metastatic process of breast cancer. Cancer Res. 65:9155–9158.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lu X, Lu X, Wang ZC, Iglehart JD, Zhang X
and Richardson AL: Predicting features of breast cancer with gene
expression patterns. Breast Cancer Res Treat. 108:191–201. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gray-Schopfer V, Wellbrock C and Marais R:
Melanoma biology and new targeted therapy. Nature. 445:851–857.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shull AY, Latham-Schwark A, Ramasamy P,
Leskoske K, Oroian D, Birtwistle MR and Buckhaults PJ: Novel
somatic mutations to PI3K pathway genes in metastatic melanoma.
PLoS One. 7:e433692012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ávalos Y, Canales J, Bravo-Sagua R,
Criollo A, Lavandero S and Quest AF: Tumor suppression and
promotion by autophagy. BioMed Res Int. 2014:6039802014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Orzechowski A, Bettuzzi S, Pawlikowska P
and Pająk B: Control of autophagy in cancer. Biomed Res Int.
2015:6987402015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Myhre S, Mohammed H, Tramm T, Alsner J,
Finak G, Park M, Overgaard J, Børresen-Dale AL, Frigessi A and
Sørlie T: In silico ascription of gene expression differences to
tumor and stromal cells in a model to study impact on breast cancer
outcome. PLoS One. 5:e140022010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
van de Vijver MJ, He YD, van't Veer LJ,
Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C,
Marton MJ, et al: A gene-expression signature as a predictor of
survival in breast cancer. N Engl J Med. 347:1999–2009. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kang Y, Siegel PM, Shu W, Drobnjak M,
Kakonen SM, Cordón-Cardo C, Guise TA and Massagué J: A multigenic
program mediating breast cancer metastasis to bone. Cancer Cell.
3:537–549. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ding L, Ellis MJ, Li S, Larson DE, Chen K,
Wallis JW, Harris CC, McLellan MD, Fulton RS, Fulton LL, et al:
Genome remodelling in a basal-like breast cancer metastasis and
xenograft. Nature. 464:999–1005. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fidler IJ and Kripke ML: Genomic analysis
of primary tumors does not address the prevalence of metastatic
cells in the population. Nat Genet. 34:232003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Welch DR: Microarrays bring new insights
into understanding of breast cancer metastasis to bone. Breast
Cancer Res. 6:61–64. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
47
|
Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao
C, Ning L, Fang Z, Wang Y, Zhang L, et al: Differentially expressed
genes between primary cancer and paired lymph node metastases
predict clinical outcome of node-positive breast cancer patients.
Breast Cancer Res Treat. 103:319–329. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Suzuki M and Tarin D: Gene expression
profiling of human lymph node metastases and matched primary breast
carcinomas: Clinical implications. Mol Oncol. 1:172–180. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Vecchi M, Confalonieri S, Nuciforo P,
Viganò MA, Capra M, Bianchi M, Nicosia D, Bianchi F, Galimberti V,
Viale G, et al: Breast cancer metastases are molecularly distinct
from their primary tumors. Oncogene. 27:2148–2158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ellsworth RE, Seebach J, Field LA, Heckman
C, Kane J, Hooke JA, Love B and Shriver CD: A gene expression
signature that defines breast cancer metastases. Clin Exp
Metastasis. 26:205–213. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yokota J: Tumor progression and
metastasis. Carcinogenesis. 21:497–503. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chambers AF, Naumov GN, Vantyghem SA and
Tuck AB: Molecular biology of breast cancer metastasis. Clinical
implications of experimental studies on metastatic inefficiency.
Breast Cancer Res. 2:400–407. 2000. View
Article : Google Scholar : PubMed/NCBI
|
